Cyclosporin A and the immune response to transplantation antigens.

A. D. Hess

Research output: Contribution to journalArticle

Abstract

Cyclosporin A (CsA) is a promising new immunosuppressive agent with considerable clinical potential. In addition to its ability to prolong allografts and possibly induce transplantation tolerance, this agent appears capable of selectively affecting different T lymphocyte subpopulations. Thus, Cyclosporin A may not only be a useful drug in clinical transplantation, but it may also become an important immunologic probe allowing the dissection of complex cellular interactions involved in the immune response.

Original languageEnglish (US)
Pages (from-to)23-27
Number of pages5
JournalLymphokine research
Volume1
Issue number2
StatePublished - Dec 1 1982

ASJC Scopus subject areas

  • Immunology
  • Hematology

Fingerprint Dive into the research topics of 'Cyclosporin A and the immune response to transplantation antigens.'. Together they form a unique fingerprint.

  • Cite this